CALVIN MIURA, M.D.
Ophthalmology Physician in HONOLULU, Hawaii. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
CALVIN MIURA, M.D. filed 788 Medicare Part D claims in 2023 as a Ophthalmology Physician in HONOLULU, Hawaii, prescribing 47% generic.
- 788
- Part D claims, 2023
- 47%
- generic prescribing
- $116.82
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
CALVIN MIURA, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
788 Top 29% higher than 71% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
CALVIN MIURA, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about CALVIN MIURA, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Hawaii
How Ophthalmology Physician compares to other specialties among Hawaii providers
Ophthalmology Physician share within Hawaii
Ophthalmology Physician is one of the more visible NUCC categories in Hawaii
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Ophthalmology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Ophthalmology Physician ABMS/AOA estimate
Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Ophthalmology Physician US NPIs
Specialty board-certified rate — Ophthalmology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
CALVIN MIURA, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 1150 SOUTH KING STREET, HONOLULU, HI, 96814, with a listed phone of (808) 947-2233. NPI 1659434025 was issued on 12/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MIURA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 788 prescription claims written by this provider, covering 166 Medicare beneficiaries and totaling roughly $181K in drug spend, split 53% brand-name and 47% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1659434025 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 12/18/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm CALVIN MIURA, M.D.'s current license status, disciplinary history, and board certifications with the Hawaii Medical Board in Hawaii before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CALVIN MIURA, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$117
Largest payer
Bausch & Lomb Americas Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
53% brand-name claims vs 47% generic, on 788 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,812
- Total Day Supply
- 53,198
- Brand vs Generic
- 53% brand / 47% generic
- Brand Drug Cost
- $156K
- Generic Drug Cost
- $25K
- Antibiotic Claims
- 16
Patient Demographics
- Average Patient Age
- 81.8 years
- Avg HCC Risk Score
- 1.29
- Gender Split
- 63% female / 37% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What CALVIN MIURA, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
228 claims
- Dorzolamide-Timolol
Dorzolamide-Timolol
147 claims
- Rocklatan 59
Rocklatan
59 claims
- Timolol Maleate 44
Timolol Maleate
44 claims
- Brimonidine Tartrate 33
Brimonidine Tartrate
33 claims
- Loteprednol Etabon… 25
Loteprednol Etabonate
25 claims
- Lumigan 25
Lumigan
25 claims
- Rhopressa 19
Rhopressa
19 claims
| Drug | Claims |
|---|---|
| Latanoprost | 228 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 147 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 59 |
| Timolol Maleate | 44 |
| Brimonidine Tartrate | 33 |
| Loteprednol Etabonate | 25 |
| Lumigan Bimatoprost | 25 |
| Rhopressa Netarsudil Mesylate | 19 |
| Travoprost | 19 |
| Vyzulta Latanoprostene Bunod | 18 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How CALVIN MIURA, M.D. fits within the Ophthalmology Physician landscape nationally.
CALVIN MIURA, M.D.'s 788 claims are below the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in Hawaii
Other clinicians with the same primary specialty enrolled in Hawaii, drawn from the same CMS NPPES roster as MIURA.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Hawaii
Frequently Asked Questions
What is CALVIN MIURA, M.D.'s specialty? ▼
How much does CALVIN MIURA, M.D. prescribe under Medicare Part D? ▼
Where is CALVIN MIURA, M.D. located? ▼
What is CALVIN MIURA, M.D.'s NPI number? ▼
Does CALVIN MIURA, M.D. prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does CALVIN MIURA, M.D. prescribe most often? ▼
Does CALVIN MIURA, M.D. accept Medicare? ▼
How can I verify CALVIN MIURA, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology